Home » Topics » Regulatory » Patents

Patents
RSS

Antihyperlipidemic agents from natural source described by Takeda

Dec. 2, 1996

Potent ACAT inhibitor discovered by Kitasato Institute

Dec. 2, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Lilly research into antiobesity proteins continues

Dec. 2, 1996

Dual-action PDE IV/TNF-alpha inhibitors reported by Janssen

Dec. 2, 1996

Novel porphycene compounds synthesized at Cytopharm

Dec. 2, 1996

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Nov. 29, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...